Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 12Brain Neoplasms 8Breast Neoplasms 5Agnosia 4Thyroid Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Emergence Delirium 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pain 2Inflammation 2Dexmedetomidine 2Delirium 2Chronic Pain 2Thrombosis 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Sedation 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Pneumoperitoneum 1Pheochromocytoma 1Opioid Consumption, Postoperative 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Propofol 3Dexmedetomidine 3Saline Solution 2remimazolam 1Sufentanil 1Ropivacaine 1Midazolam 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Emergence Delirium × Dexmedetomidine × Clear all
NCT06863064 2025-03-07

Brain Tumor Surgery and Postoperative Delirium

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase NA Not yet recruiting
140 enrolled
CNS

Emergence Delirium, Brain Neoplasms

NCT06164314 2025-02-17

Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors

Beijing Tiantan Hospital

Phase NA Recruiting
366 enrolled

Emergence Delirium

NCT04674241 2022-04-04

Dexmedetomidine Alleviates Postoperative Delirium After Brain Tumor Resections

Beijing Tiantan Hospital

Phase NA Completed
260 enrolled

Emergence Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡